- Clinical science
Paraneoplastic syndromes are a set of clinical features that are caused by either an altered immune response to a systemic malignancy or because of substances (e.g., hormones, cellular proteins) produced by tumors. They are caused neither by the local mass effect nor by metastasis of the associated cancer. Paraneoplastic syndromes present with a wide range of findings and are most commonly associated with lung, ovarian, lymphatic, and breast cancers. Small cell lung cancer is especially notorious for its numerous and distinct paraneoplastic syndromes. Some paraneoplasias are associated with many different malignancies, such as tumor-induced hypercalcemia, which is caused by parathyroid hormone-related protein (PTHrP) produced from tumor cells. Other paraneoplasias (e.g., malignant acanthosis nigricans) are almost pathognomonic for specific malignancies and their presence demands an immediate search for the underlying tumor. A general overview of the most common paraneoplastic syndromes and their associations is presented here. Further details for individual syndromes can be found in articles of associated conditions.
- Common paraneoplastic manifestations: cachexia, hyperthermia, increased risk of thrombosis
- Specific paraneoplasias
|Type||Syndrome||Underlying cause||Associated cancer(s)|
| || |
|Neurological|| || |
|Skeletal|| || || |
|Hematological|| || || |
|Miscellaneous|| || |
To recall the neoplasias associated with polycythemia think of “Rising or high hematocrit levels are paraneoplastic!” R - Renal cell carcinoma, H - Hepatocellular carcinoma, H - Hemangioblastoma, L - Leiomyoma, P - Pheochromocytoma.